Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Invested Capital (2019 - 2022)

Historic Return on Invested Capital for Regenxbio (RGNX) over the last 4 years, with Q4 2022 value amounting to 0.49%.

  • Regenxbio's Return on Invested Capital fell 7200.0% to 0.49% in Q4 2022 from the same period last year, while for Dec 2022 it was 0.49%, marking a year-over-year decrease of 7200.0%. This contributed to the annual value of 0.65% for FY2023, which is 2400.0% down from last year.
  • Latest data reveals that Regenxbio reported Return on Invested Capital of 0.49% as of Q4 2022, which was down 7200.0% from 0.15% recorded in Q3 2022.
  • Regenxbio's Return on Invested Capital's 5-year high stood at 0.24% during Q4 2021, with a 5-year trough of 0.49% in Q4 2022.
  • Moreover, its 4-year median value for Return on Invested Capital was 0.25% (2020), whereas its average is 0.17%.
  • Over the last 5 years, Regenxbio's Return on Invested Capital had its largest YoY gain of 5900bps in 2022, and its largest YoY loss of -7200bps in 2022.
  • Quarter analysis of 4 years shows Regenxbio's Return on Invested Capital stood at 0.32% in 2019, then increased by 2bps to 0.31% in 2020, then surged by 177bps to 0.24% in 2021, then tumbled by -306bps to 0.49% in 2022.
  • Its Return on Invested Capital stands at 0.49% for Q4 2022, versus 0.15% for Q3 2022 and 0.16% for Q2 2022.